{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:25:15Z","timestamp":1780395915196,"version":"3.54.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167757","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T06:26:17Z","timestamp":1481351177000},"page":"e0167757","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Anti-TNF-\u03b1 Drugs Differently Affect the TNF\u03b1-sTNFR System and Monocyte Subsets in Patients with Psoriasis"],"prefix":"10.1371","volume":"11","author":[{"given":"Lara","family":"Gibellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Biasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Trenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Pinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-1558","authenticated-orcid":true,"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/jdv.13235","article-title":"Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-alpha monoclonal antibody: an observational multicenter study","volume":"29","author":"M Ardigo","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"CE Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"MA Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/bjd.12735","article-title":"Diet and physical exercise in psoriasis: a randomized controlled trial","volume":"170","author":"L Naldi","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2340\/00015555-0669","article-title":"Relevance of psychosomatic factors in psoriasis: a case-control study","volume":"89","author":"S Jankovi\u0107","year":"2009","journal-title":"Acta Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bjd.12478","article-title":"Does psychosocial stress play a role in the exacerbation of psoriasis?","volume":"169","author":"HJ Hunter","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","article-title":"Triggering psoriasis: the role of infections and medications","volume":"25","author":"L Fry","year":"2007","journal-title":"Clin Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0923-1811(96)00562-2","article-title":"Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments","volume":"14","author":"H Mizutani","year":"1997","journal-title":"J Dermatol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","article-title":"Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI","volume":"305","author":"J Romani","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.4049\/jimmunol.171.5.2262","article-title":"TNF skews monocyte differentiation from macrophages to dendritic cells","volume":"171","author":"P Chomarat","year":"2003","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"F Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.12.9.1085","article-title":"Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis","volume":"12","author":"F Fantuzzi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","volume":"58","author":"A Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1365-2133.2005.06688.x","article-title":"A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction","volume":"152","author":"KA Papp","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"K Reich","year":"2005","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/jdv.13024","article-title":"TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients","volume":"29","author":"C De Simone","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2217\/pgs.11.114","article-title":"Genetic and genomic predictors of anti-TNF response","volume":"12","author":"R Prajapati","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.12425","article-title":"The relationship between tumour necrosis factor (TNF)-alpha promoter and IL12B\/IL-23R genes polymorphisms and the efficacy of anti-TNF-alpha therapy in psoriasis: a case-control study","volume":"169","author":"E Gallo","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03256427","article-title":"Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population","volume":"16","author":"Y Vasilopoulos","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"F Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e50728","DOI":"10.1371\/journal.pone.0050728","article-title":"T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy","volume":"7","author":"A Cossarizza","year":"2012","journal-title":"PloS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12916-015-0515-0","article-title":"Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments","volume":"13","author":"S De Biasi","year":"2015","journal-title":"BMC Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cyto.a.20901","article-title":"Data analysis in flow cytometry: the future just started","volume":"77","author":"E Lugli","year":"2010","journal-title":"Cytometry A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.1038\/srep13886","article-title":"Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous","volume":"5","author":"R Mukherjee","year":"2015","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/1744666X.4.2.275","article-title":"Autoantibody production in patients treated with anti-TNF-alpha","volume":"4","author":"F Atzeni","year":"2008","journal-title":"Exp Rev Clin Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.1999.00622.x","article-title":"Cytokines in psoriasis","volume":"38","author":"C Bonifati","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/ibd.20899","article-title":"Incidence and clinical significance of immunogenicity to infliximab in Crohn&apos;s disease: a critical systematic review","volume":"15","author":"A Cassinotti","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bjd.12654","article-title":"Antidrug antibodies in psoriasis: a systematic review","volume":"170","author":"L Hsu","year":"2014","journal-title":"Br J Dermatology"},{"key":"ref30","first-page":"E294","article-title":"Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha","volume":"275","author":"G Paolisso","year":"1998","journal-title":"Am J Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.jidsymp.5650032","article-title":"Effects of etanercept are distinct from infliximab in modulating proinflammatory genes in activated human leukocytes","volume":"12","author":"AS Haider","year":"2007","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.jid.5701064","article-title":"Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome","volume":"128","author":"AS Haider","year":"2008","journal-title":"The J Invest Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"S Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","article-title":"Blood monocytes: development, heterogeneity, and relationship with dendritic cells","volume":"27","author":"C Auffray","year":"2009","journal-title":"Ann Rev Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9","article-title":"Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis","volume":"43","author":"D Baeten","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1572-0241.2007.01714.x","article-title":"Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease","volume":"103","author":"H Hanai","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40169-014-0040-3","article-title":"Clinical significance of monocyte heterogeneity","volume":"4","author":"BK Stansfield","year":"2015","journal-title":"Clin Transl Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1186\/ar3928","article-title":"Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis","volume":"14","author":"L Chara","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cei.12375","article-title":"Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection","volume":"177","author":"N Nazareth","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2036.2005.02309.x","article-title":"Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept","volume":"21","author":"C Shen","year":"2005","journal-title":"Aliment Pharmacol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:46:42Z","timestamp":1589014002000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167757"}},"subtitle":[],"editor":[{"given":"Yolande","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167757","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}